share_log

Xenon Pharmaceuticals | 424B5: Prospectus

SEC ·  Mar 1, 2022 16:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more